OGT and cervical cancer: Moreover, depleting OGT levels with OGT-specific shRNA significantly reduced levels of HCF-1 in HeLa cervical cancer cells as shown by western blot analysis (Figure 4B, P < 0.0001), supporting a role for OGT in stabilizing HCF-1 protein.